Hammer Asset Management’s Pfizer PFE Stock Holding History

Hammer Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$495K	Sell	13,446 -3,530	-21%	-$129K	2.4%	21
2020 Q3	$591K	Sell	16,976 -9,339	-35%	-$327K	2.63%	15
2020 Q2	$816K	Sell	26,315 -2,971	-10%	-$101K	2.33%	18
2020 Q1	$907K	Sell	29,286 -59,600	-67%	-$2.03M	2.85%	11
2019 Q4	$3.3M	Sell	88,886 -762	-0.8%	-$27.1K	2.49%	12
2019 Q3	$3.06M	Sell	89,648 -17	-0%	-$618	2.43%	12
2019 Q2	$3.69M	Sell	89,665 -26	-0%	-$1.03K	3.04%	3
2019 Q1	$3.61M	Buy	89,691 +101	+0.1%	+$4.04K	3.19%	6
2018 Q4	$3.71M	Sell	89,590 -184	-0.2%	-$7.64K	3.62%	2
2018 Q3	$3.75M	Sell	89,774 -10,579	-11%	-$407K	3.07%	4
2018 Q2	$3.09M	Buy	+100,353	New	+$3.43M	2.71%	14

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Hammer Asset Management's PFE Position: Q4 2020 in Review

Hammer Asset Management reduced its Pfizer (PFE) stake by 21% in Q4 2020, selling an estimated $129K and leaving 13,446 shares worth $495K. The position accounts for 2.4% of the portfolio, ranked #21.

Hammer Asset Management first reported a position in PFE in Q2 2018 and has held it in 11 quarters since. The position peaked at $3.75M in Q3 2018. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

Hammer Asset Management held 13,446 shares of Pfizer worth $495K as of Q4 2020.
Hammer Asset Management sold 3,530 Pfizer shares in Q4 2020, an estimated $129K.
Pfizer made up 2.4% of Hammer Asset Management's portfolio in Q4 2020, its #21 holding.
Hammer Asset Management first reported a position in Pfizer in Q2 2018 and has held it in 11 quarters since.
Hammer Asset Management's Pfizer position peaked at $3.75M in Q3 2018.
2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Hammer Asset Management's 13F filing for Q4 2020, filed 19 Jan 2021.